Evidence map›Paper›PMID 34599387›Full record

ReviewCurrent cardiology reports2021

Septal Ablation Versus Surgical Myomectomy for Hypertrophic Obstructive Cardiomyopathy.

F Pelliccia, H Seggewiss, F Cecchi, P Calabrò, G Limongelli, O Alfieri, P Ferrazzi, M H Yacoub, I Olivotto

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current cardiology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 3 countries.

F PellicciaDepartment of Cardiovascular Sciences, University Sapienza, Via del Policlinico 155, 00161, Rome, Italy. f.pelliccia@mclink.it.ORCID http://orcid.org/0000-0003-1260-1308
H SeggewissComprehensive Heart Failure Center (CHFC), Deutsches Zentrum Für Herzinsuffizienz (DZHI), Universitätsklinikum Würzburg, Würzburg, Germany.
F CecchiDepartment of Cardiovascular, Neural and Metabolic Sciences, IRCCS Istituto Auxologico Italiano, San Luca Hospital, Milan, Italy.
P CalabròDepartment of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
G LimongelliDepartment of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
O AlfieriDepartment of Cardiovascular and Thoracic Surgery, San Raffaele University Hospital, Milan, Italy.
P FerrazziHypertrophic Cardiomyopathy Center, Policlinico Di Monza, Monza, Italy.
M H YacoubHeart Science Centre, National Heart and Lung Institute, Imperial College London, London, UK.
I OlivottoCardiomyopathy Unit, Careggi University Hospital, Florence, Italy.
Azienda Ospedaliero-Universitaria Careggi · ITImperial College London · GBIRCCS Istituto Auxologico Italiano · ITPoliclinico Umberto I · ITSan Raffaele University of Rome · ITSt Bartholomew's Hospital · GBUniversitätsklinikum Würzburg · DEUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewPatients with hypertrophic cardiomyopathy (HCM) who have left ventricular outflow tract obstruction (LVOTO) often experience severe symptoms and functional limitation. Relief of LVOTO can be achieved by two invasive interventions, i.e., surgery myectomy and alcohol septal ablation (ASA), leading in experienced hands to a dramatic improvement in clinical status. Despite extensive research, however, the choice of the best option in individual patients remains challenging and poses numerous clinical dilemmas. RECENT

findingsInvasive strategies have been recently incorporated in recommendations for the diagnosis and treatment of HCM on both sides of the Atlantic. These guidelines are based on a bulk of well-designed but retrospective studies as well as on expert opinions. Evidence now exists that adequate evaluation and management of HCM requires a multidisciplinary team capable of choosing the best available options. Management of LVOTO still varies largely based on local expertise and patient preference. Following the trend that has emerged for other cardiac diseases amenable to invasive interventions, the concept of a "HCM heart team" is coming of age.

Indexed as

Cardiac Surgical ProceduresCardiomyopathy, HypertrophicCatheter AblationUterine MyomectomyFemaleHumansRetrospective StudiesAlcohol septal ablationGradientHypertrophic cardiomyopathyLeft ventricular outflow tractMyectomyObstruction

Identifiers

PMID34599387
PMCPMC8486700
OpenAlexW3202399686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.